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30 Multiple Choice Questions: ½mark each 
Total No of Marks for this section: 15  
 
• Answer ALL thirty (30) questions in this section on the multiple choice answer booklet 
provided. Please ensure to write your names and student number on the answer booklet 
• Indicate your answer by a tick (✓) in the correct box 
• Where there is change of mind, put a cross (X) through the wrong one, and tick (✓) the 
correct option 
• Note that ALL questions in this section are of equal value as indicated. 
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Section B 
Short Answer Questions 
Total No of Marks for this section: 60   
 
• Answer ALL twelve (12) questions in this section; and on the space provided on the exam 
paper. 
• Note that the question values are indicated. 
• Suggested Time allocation for Section B:  90mins 
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Question 1 
A sample from Marlene Robinson, Hospital Number 2659873, date of birth 25/01/1948 
demonstrated a positive antibody screen during routine pre-admission screening for an 
orthopaedic surgery operation.  Results of testing with an antibody identification panel are shown.  
Refer to her antibody identification panel to answer the following questions: 
a) What does IAT stand for? 
(Mark: 0.5) 
b) What does the IAT phase of the reaction suggest regarding the immunoglobulin class of 
antibody? 
(Mark: 0.5) 
c) Is this an alloantibody or an autoantibody? 
 
(Mark: 0.5) 
d) What is the most likely antibody specificity? 
 
(Mark: 1) 
e) Are there antibodies that cannot be ruled out at all on this panel?  What are they? 
 
(Mark: 1) 




g) What are the two possible causes of the production of this antibody in this patient? 
(Mark: 1) 
 
h) Referring to the antigram, which cell or cells are homozygous for the Fy(a) antigen? 
(Mark: 0.5) 
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Question 2 
Fill in the interpretations of the following ABO and D group reactions 
 
Anti-A Anti-B Anti-D A1 cells B cells Group 
12 0 12 0 12  
0 0 0 12 12  
12 0 0 0 12  
12 12 0 0 0  
0 12 0 12 0  
0 0 12 12 12  
12 12 12 0 0  




The following reactions were obtained by testing red cells from a patient with Rh blood group 
antisera: 
 
Anti-D Anti-C Anti-E Anti-c Anti-e 
0 0 0 12 12 
a) What Rh antigens does the patient possess?  
(Mark: 1) 
b) What is the most probable Rh genotype? 
(Mark: 1) 
c) What is the Rh phenotype? 
(Mark: 1) 
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A 60 year old woman with anaemia is admitted to hospital.  Her Hb is 64g/L and she has been 
experiencing ongoing subtle gastrointestinal bleeding over many weeks.  Her doctor requests two 
units of red cells for transfusion before going to theatre.   
 
Upon testing her blood group is AB Positive and her antibody screen is negative. 
 
Her previous transfusion history is checked and it’s discovered that she had an anti-E previously 
detected 3 years ago. 
 
In your hospital red cell inventory you don’t routinely stock group AB Positive red cells. 
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A 23 year old female has been in a motorbike accident and the doctors are suspecting that she has 
a fractured both her legs.  A sample and request are sent to the lab for ‘group and hold’ testing 
before she goes to theatre. 
 
a) Before collecting a group and hold specimen what is the most important thing that the 




The following ABO and Rh(D) results are obtained: 
 
Anti-A Anti-B Anti-D A1 cells B cells 
0 0 0 12 12 
 
 
b) What is the ABO and Rh(D) interpretation? 
 
(Mark: 0.5) 




d) If she started bleeding significantly in theatre and donor blood of her type was in very short 














Semester 1, 2016 FINAL EXAMINATION 




A 36 year old female patient is transfused four units of red cells in theatre after experiencing a 
massive post-partum haemorrhage.  Prior going to theatre she was confirmed to be group A Rh(D) 
Positive and her antibody screen was negative.   
The surgeons managed to stop all of her bleeding and after the transfusions her Hb was 93g/L 
when tested the next day.  Five days later the patient is still in hospital and is starting to feel faint 
with other symptoms of jaundice and lethargy.  A full blood count examination is performed on 
which shows the patient’s Hb is 65g/L. 
a) Given that she is no longer bleeding what may be a possible explanation as to why her Hb 
has dropped so quickly?  
 
(Mark: 1) 




c) After testing the patient’s post-transfusion specimen, the antibody screen is positive and 
you identify an anti-Jk(b).  Given the clinical scenario is it likely that this is a primary or 
secondary immune response? 
(Mark: 1) 
 
d) For her future transfusion requirements what specific red cells must she be transfused with 
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Question 7 
Patient Chloe Burke has a positive pregnancy screening test and has been referred to the 
Antenatal Clinic at your hospital for her initial visit at 10 weeks gestation.  This is her first 
pregnancy. 
Testing shows that she is group O Rh(D) Negative with a negative antibody screen.   
a) Does Chloe Burke meet the criteria for Rh(D) Immunoglobulin prophylaxis during her 
pregnancy?  Why/why not? 
           (Mark: 0.5) 
b) Just after she has her appointment at the Antenatal Clinic at 10 weeks gestation Chloe is 
involved in a minor car accident and experiences some minor abdominal trauma.  What 
dose of Rh(D) Immunoglobulin should she receive? 
           (Mark: 0.5) 
c) At 28 weeks gestation Chloe has another appointment at the Antenatal Clinic?  What Blood 




d) The lab testing finds Chloe’s antibody screen is weakly positive and detects an anti-D on 
the antibody identification panel.  List two causes of the anti-D detected. 
 
(Mark: 2) 
12 weeks later Chloe delivers a very healthy baby girl. 
e) Baby of Chloe Burke’s blood group is tested and found to be O Rh(D) Negative does Chloe 
need to receive any further injections of Rh(D) Immunoglobulin?  Why/why not? 
(Mark: 1) 
f) Does Chloe need to have a Kleihauer-Betke test performed post-partum?   
 
           (Mark: 0.5) 
 
g) Chloe’s partner thinks that his blood group is AB Rh(D) Positive.  If this is true is he the 
father of Chloe’s baby? 
           (Mark: 0.5) 
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b) When donor red cells are received in the laboratory what test must be performed before 



























Semester 1, 2016 FINAL EXAMINATION 










b) List 2 non-immune-mediated adverse complications of transfusion: 
(Mark: 2) 













Semester 1, 2016 FINAL EXAMINATION 




Patient Kate Wilson, hospital number 193854, date of birth 13/10/1995 has presented to your 
hospital in advanced stages of labour.  She has had no antenatal care during her pregnancy.  A 
sample is taken for group and hold.   
 
Her group is O Positive and the antibody screen is positive. 
 
Results of testing with an antibody identification panel are shown.  Refer to her antibody 
identification panel to answer the following questions: 
 










Full phenotyping is performed with the following results: 
CDe (R1R1), K+, Fy(a+b+), Jk(a+b+), M+N+S+s+, P1-, Le(a-b+) 
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f) Does this antibody have any possible complications for the baby she is about to deliver?  If 
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List four aspects of quality control in the Blood Bank laboratory. 
1. 
2. 
3. 
4.  
 
(Mark: 2) 
 
 
 
